| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7405193 |
Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation |
Jul. 29, 2008 |
| 7405192 |
Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
Jul. 29, 2008 |
| 7404961 |
Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins |
Jul. 29, 2008 |
| 7404957 |
Modified IL-4 mutein receptor antagonists |
Jul. 29, 2008 |
| 7403883 |
Three-dimensional in-vitro spinal models and methods of analyzing substance distribution therein |
Jul. 22, 2008 |
| 7402599 |
Protein structures and protein fibres |
Jul. 22, 2008 |
| 7402567 |
Treatment of disease by inducing cell apoptosis |
Jul. 22, 2008 |
| 7402565 |
Processes for making acylated insulin |
Jul. 22, 2008 |
| 7402564 |
Synthetic peptide amides |
Jul. 22, 2008 |
| 7402563 |
EPF derived peptides and therapeutic compositions |
Jul. 22, 2008 |
| 7402562 |
Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
Jul. 22, 2008 |
| 7402561 |
Compositions and methods for inhibiting abnormal cell growth |
Jul. 22, 2008 |
| 7402560 |
NCAM binding compounds |
Jul. 22, 2008 |
| 7402559 |
Composition and method of treatment for urogenital conditions |
Jul. 22, 2008 |
| 7402558 |
Method for aiding implantation or decreasing miscarriage rate |
Jul. 22, 2008 |
| 7402557 |
Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
Jul. 22, 2008 |
| 7402556 |
Prodrugs activated by plasmin and their use in cancer chemotherapy |
Jul. 22, 2008 |
| 7402316 |
Group A streptococcal vaccines |
Jul. 22, 2008 |
| 7402315 |
Hepatitis-C virus type 4, 5 and 6 |
Jul. 22, 2008 |
| 7402314 |
In vivo activation of tumor-specific cytotoxic T cells |
Jul. 22, 2008 |
| 7399746 |
Agents for wound healing |
Jul. 15, 2008 |
| 7399745 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
Jul. 15, 2008 |
| 7399742 |
Anti-osteolytic therapy involving adiponectin |
Jul. 15, 2008 |
| 7399741 |
Notch |
Jul. 15, 2008 |
| 7399740 |
Poly-Glu,Tyr for neuroprotective therapy |
Jul. 15, 2008 |
| 7399739 |
Vertebral augmentation composition and method |
Jul. 15, 2008 |
| 7399612 |
VEGF-binding fusion proteins and nucleic acids encoding the same |
Jul. 15, 2008 |
| 7399489 |
Exendin analog formulations |
Jul. 15, 2008 |
| 7399476 |
Nucleic acid free ghost preparations |
Jul. 15, 2008 |
| 7399464 |
Polypeptides of the IFN.alpha.-7 gene |
Jul. 15, 2008 |
| 7396816 |
Low-molecular weight peptides inhibiting ion channel activity |
Jul. 8, 2008 |
| 7396813 |
Method for inhibiting insects with an insect cadherin ectodomain |
Jul. 8, 2008 |
| 7396812 |
Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
Jul. 8, 2008 |
| 7396811 |
Subcellular targeting of therapeutic proteins |
Jul. 8, 2008 |
| 7396810 |
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
Jul. 8, 2008 |
| 7396809 |
Methods and reagents for treating glucose metabolic disorders |
Jul. 8, 2008 |
| 7396664 |
VEGF-binding fusion proteins and nucleic acids encoding the same |
Jul. 8, 2008 |
| 7396536 |
Parasitic helminth cuticlin proteins and uses thereof |
Jul. 8, 2008 |
| 7393837 |
Inhibition of PEX in the treatment of metabolic bone diseases |
Jul. 1, 2008 |
| 7393831 |
Peptide compositions and their use against HCV |
Jul. 1, 2008 |
| 7393828 |
Modified MscL protein channel |
Jul. 1, 2008 |
| 7393827 |
Pharmaceutical compositions and methods for restoring .beta.-cell mass and function |
Jul. 1, 2008 |
| 7393826 |
Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
Jul. 1, 2008 |
| 7393825 |
Microdose therapy |
Jul. 1, 2008 |
| 7393824 |
Methods of peptide preparation |
Jul. 1, 2008 |
| 7393823 |
HER-2 binding antagonists |
Jul. 1, 2008 |
| 7393660 |
CC-chemokine binding tick proteins |
Jul. 1, 2008 |
| 7393538 |
Clostridial toxin treatment for dermatillomania |
Jul. 1, 2008 |
| 7393537 |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder |
Jul. 1, 2008 |
| 7393534 |
Compositions and methods for immunotherapy of cancer and infectious diseases |
Jul. 1, 2008 |
|
|
|
